More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

Completion institutional entitlement offer and placement

Jun 29, 2016 at 11:09 PM EDT · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Jun 29, 2016 at 11:09 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/completion-institutional-entitlement-offer-and-placement-2

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26↗

Mayne Pharma Group Ltd. on 6ix

Story so far

  • Mayne Pharma successfully completes US$125m debt financingFeb 11, 2016
  • Completion institutional entitlement/unconditional placementFeb 11, 2016
  • Completion of placementFeb 11, 2016

Earlier from Mayne Pharma

  • MYX announces acquisition of US generic product portfolioJun 27, 2016
  • MYX receives first generic approval of Tikosyn capsulesJun 6, 2016
  • Mayne Pharma receives FDA approval for Doryx MPC tabletsMay 23, 2016
  • 2015 Appendix 4E & Annual ReportFeb 11, 2016
  • US Sales of Doryx UpdateFeb 10, 2016

Later from Mayne Pharma

  • MYX announces settlement from patent infringement caseJul 29, 2016
  • MYX announces acquisition of US foam dermatology assetsAug 17, 2016
  • Appendix 4E, Directors Report and Financial StatementsAug 25, 2016
  • MYX launches generic Entocort EC (Budesonide) capsulesOct 26, 2016
  • IDT: 1st generic proprietary prod shipped to US, temozolomideNov 1, 2016
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer